| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1164/AJRCCM/152.4_PT_2.S59 |
| P698 | PubMed publication ID | 7551415 |
| P2093 | author name string | Openshaw PJ | |
| P433 | issue | 4 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S59-62 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Immunity and immunopathology to respiratory syncytial virus. The mouse model | |
| P478 | volume | 152 |
| Q45754571 | A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology |
| Q35571206 | A hypothesis: antenatal sensitisation to respiratory syncytial virus in viral bronchiolitis |
| Q45644291 | Age related differences in humoral immune response to respiratory syncytial virus infection in adults |
| Q35533594 | Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families |
| Q44093134 | Asthma and respiratory syncytial virus infection in infancy: is there a link? |
| Q73878837 | Bovine respiratory syncytial virus |
| Q26775152 | Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease |
| Q38958802 | C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine |
| Q33712590 | CD8+ TCR transgenic strains expressing public versus private TCR targeting the respiratory syncytial virus K(d)M2(82-90) epitope demonstrate similar functional profiles |
| Q43690717 | CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein |
| Q30300567 | Challenges and opportunities in developing respiratory syncytial virus therapeutics |
| Q45733304 | Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture |
| Q45746586 | Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice |
| Q31123002 | Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR. |
| Q33785332 | Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine |
| Q30824914 | Dual-energy X-ray absorptiometry in small subjects: influence of dual-energy X-ray equipment on assessment of mineralization and body composition in newborn piglets |
| Q36810987 | Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma |
| Q45009841 | Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma |
| Q36803900 | Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma |
| Q33603913 | HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein |
| Q40597806 | Human Respiratory Syncytial Virus: An Introduction. |
| Q37683019 | Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies |
| Q25256827 | Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice |
| Q34430368 | IL-4 attenuates pulmonary epithelial cell-mediated suppression of T cell priming |
| Q36003444 | Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model |
| Q40595357 | Immunopathogenesis of vaccine-enhanced RSV disease. |
| Q37252640 | In situ evolution of virus-specific cytotoxic T cell responses in the lung |
| Q33848810 | Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus |
| Q83400970 | Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV |
| Q45627167 | Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. |
| Q33539600 | Maturation of immune responses at the beginning of asthma |
| Q34990420 | Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease |
| Q33692384 | Nasopharyngeal aspirate & blood cytokine profile in infants hospitalized for respiratory syncytial virus bronchiolitis: A pilot study from south India |
| Q35124942 | Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection |
| Q34204623 | Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development |
| Q37880221 | Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses |
| Q35890400 | Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent |
| Q45745873 | Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis |
| Q57987138 | Pneumovirus and Metapneumovirus: Respiratory Syncytial Virus and Human Metapneumovirus |
| Q45491056 | Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy |
| Q41435453 | Problems and prospects of developing effective therapy for common cold viruses |
| Q31055398 | Progressive epitope-blocked panning of a phage library for isolation of human RSV antibodies |
| Q37721415 | Prospects for defined epitope vaccines for respiratory syncytial virus |
| Q36994716 | RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. |
| Q37467911 | Reduced clearance of respiratory syncytial virus infection in a preterm lamb model |
| Q42855455 | Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus |
| Q33648461 | Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. |
| Q44237000 | Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells |
| Q33797058 | Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice |
| Q40678750 | Respiratory syncytial virus infection and virus-induced inflammation are modified by contaminants of indoor air. |
| Q33961877 | Respiratory syncytial virus infection in adults |
| Q36935746 | Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration |
| Q37369842 | Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen |
| Q33588916 | Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment |
| Q45740485 | Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice |
| Q30448788 | Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease |
| Q53611079 | Suppression of IFN-gamma production in atopic group at the acute phase of RSV infection. |
| Q42496152 | Systemic eosinophil response induced by respiratory syncytial virus |
| Q35056722 | TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization |
| Q33833220 | Th1/Th2 balance in infection |
| Q38625810 | Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins |
| Q38561753 | The changing landscape of respiratory syncytial virus |
| Q33863111 | The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin |
| Q43442877 | The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice |
| Q37263779 | The host response and molecular pathogenesis associated with respiratory syncytial virus infection |
| Q45709995 | The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B. |
| Q33870192 | The interaction of neutrophils with respiratory epithelial cells in viral infection |
| Q34549253 | The use of a neonatal mouse model to study respiratory syncytial virus infections |
| Q30305830 | Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. |
| Q33558356 | Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice |
| Q34033765 | Viruses and atopic sensitization in the first years of life |
| Q73571895 | [Bronchiolitis in infants. Natural history of the disease] |
Search more.